A new review was published in Oncotarget, Volume 16, on February 12, 2025, titled “SETDB1 amplification in osteosarcomas: ...
Davis Randle's teammates said the strength he's showed throughout the struggle of battling cancer has motivated them all ...
OS Therapies, Inc. (NYSE-A: OSTX) entered into agreements for the commercial manufacture of OST-HER2. The company is ...
SCIENTISTS have called for more people to be aware of symptoms caused by an aggressive form of cancer striking children and teens. Over 150 cases of the disease are spotted in the UK every year ...
New research using data from the 100,000 Genomes Project has identified a genetic change that drives osteosarcoma, an ...
Our team has demonstrated the presence of SETDB1 abnormalities, particularly its amplification, through WES analysis of osteosarcoma human samples ...